Abstract:Purpose of review: Opioid receptors are widely expressed in the human brain. A number of features commonly associated with drug use disorder, such as difficulties in emotional learning, emotion regulation and anhedonia, have been linked to endogenous opioid signalling. Whereas chronic substance use and misuse are thought to alter the function of the mu-opioid system, the specific mechanisms are not well understood. We argue that understanding exogenous and endogenous opioid effects in the healthy human brain is an essential foundation for bridging preclinical and clinical findings related to opioid misuse. Here, we will examine psychopharmacological evidence to outline the role of the mu-opioid receptor (MOR) system in the processing of threat and reward, and discuss how disruption of these processes by chronic opioid use might alter emotional learning and reward responsiveness. Recent findings: In healthy people, studies using opioid antagonist drugs indicate that the brain's endogenous opioids downregulate fear reactivity and upregulate learning from safety. At the same time, endogenous opioids increase the liking of and motivation to engage with high reward value cues. Studies of acute opioid agonist effects indicate that with non-sedative doses, drugs such as morphine and buprenorphine can mimic endogenous opioid effects on liking and wanting. Disruption of endogenous opioid signalling due to prolonged opioid exposure is associated with some degree of anhedonia to non-drug rewards; however, new results leave open the possibility that this is not directly opioid-mediated. Summary: The available human psychopharmacological evidence indicates that the healthy mu-opioid system contributes to the regulation of reward and threat processing. Overall, endogenous opioids can subtly increase liking and wanting responses to a wide variety of rewards, from sweet tastes to feelings of being connected to close others. For threat-related processing, human evidence suggests that endogenous opioids inhibit fear conditioning and reduce the sensitivity to aversive stimuli, although inconsistencies remain. The size of effects reported in healthy humans are however modest, clearly indicating that MORs play out their role in close concert with other neurotransmitter systems. Relevant candidate systems for future research include dopamine, serotonin and endocannabinoid signalling. Nevertheless, it is possible that endogenous opioid fine-tuning of reward and threat processing, when unbalanced by e.g. opioid misuse, could over time develop into symptoms associated with opioid use disorder, such as anhedonia and depression/anxiety.

Roles of Β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism.

[Recent findings in biochemistry and the significance of endorphins and enkephalins]

Is the pursuit of happiness the pursuit of homeostasis? A review on the modulatory functions of endorphins on human behavior

Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience

Endogenous reward mechanisms and their importance in stress reduction, exercise and the brain

The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies

Investigating beta-endorphins: ways to boost health, conventional and future detection methods

Endorphins and exercise

Reward processing by the opioid system in the brain

Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review

Role of Endorphins in Breast Cancer Pathogenesis and Recovery

Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics

β-Endorphin in vitro inhibition of striatal dopamine release

Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies

Opioid system and human emotions

Role of Opioidergic System in Regulating Depression Pathophysiology.

Food-Derived Opioid Peptides in Human Health: A Review

The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis

Interactions Between Endogenous Opioids and the Immune System

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress

Dynamic Interactions Between Plasma IL-1 Family Cytokines and Central Endogenous Opioid Neurotransmitter Function in Humans